Shopping Cart
Remove All
Your shopping cart is currently empty
Sirukumab (CNTO-136) is a selective humanized monoclonal antibody binding to Interleukin-6 (IL-6), inhibiting IL-6-mediated signal transduction and activation of transcription factors. It is used in lupus nephritis and rheumatoid arthritis research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $239 | In Stock | In Stock | |
| 5 mg | $645 | In Stock | In Stock | |
| 10 mg | $953 | - | In Stock | |
| 25 mg | $1,390 | - | In Stock | |
| 50 mg | $1,880 | - | In Stock |
| Description | Sirukumab (CNTO-136) is a selective humanized monoclonal antibody binding to Interleukin-6 (IL-6), inhibiting IL-6-mediated signal transduction and activation of transcription factors. It is used in lupus nephritis and rheumatoid arthritis research. |
| Synonyms | CNTO-136, CNTO136 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Molecular Weight | 144.6 (kDa) |
| Cas No. | 1194585-53-9 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.